Label

How We Work

Grant

Back

Print

Statens Serum Institut


November 2012
to develop an economically donor-friendly IPV vaccine with a reduced IPV dose of at least 5 fold. This vaccine will despite the lower dose of IPV show an immunogenicity which equals or surpasses the current full dose IPV vaccine.
$551,049
20
Discovery and Translational Sciences
GLOBAL|EUROPE
Global Health
Copenhagen S.
http://www.ssi.dk

Visit Our Blog